Clinical trial
A Multicenter, Double-blind, Placebo-parallel-controlled Phase Ⅱ Clinical Trial to Evaluate the Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 in Patients With Acne Vulgaris
NCT07345390 is registered in ClinicalTrials.gov with Jiangxi Kvvit Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Double-blind, Placebo-parallel-controlled Phase Ⅱ Clinical Trial to Evaluate the Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 in Patients With Acne Vulgaris
- Lead sponsor
- Jiangxi Kvvit Pharmaceutical Co., Ltd.
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- January 10, 2026
- Completion date
- November 30, 2026
- Enrollment
- 180 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.